MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
2.230
+0.090 (4.21%)
At close: Mar 6, 2026, 4:00 PM EST
2.154
-0.076 (-3.40%)
After-hours: Mar 6, 2026, 5:48 PM EST
MacroGenics Employees
MacroGenics had 341 employees as of December 31, 2024. The number of employees increased by 2 or 0.59% compared to the previous year.
Employees
341
Change (1Y)
2
Growth (1Y)
0.59%
Revenue / Employee
$374,270
Profits / Employee
-$222,540
Market Cap
141.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 183 |
| Innate Pharma | 174 |
| Zentalis Pharmaceuticals | 166 |
| Adagene | 138 |
| Artiva Biotherapeutics | 106 |
| Connect Biopharma Holdings | 62 |
| Spero Therapeutics | 32 |
| Corbus Pharmaceuticals Holdings | 28 |
MGNX News
- 9 days ago - MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 12 days ago - MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial - GlobeNewsWire
- 3 months ago - MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 4 months ago - MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress - GlobeNewsWire
- 4 months ago - MacroGenics to Participate in the Stifel 2025 Healthcare Conference - GlobeNewsWire
- 6 months ago - MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities - GlobeNewsWire
- 7 months ago - MacroGenics Appoints Eric Risser as President and Chief Executive Officer - GlobeNewsWire